| Product NDC: | 52533-034 |
| Proprietary Name: | Labetalol HCl |
| Non Proprietary Name: | Labetalol HCl |
| Active Ingredient(s): | 5 mg/mL & nbsp; Labetalol HCl |
| Administration Route(s): | INTRAVENOUS |
| Dosage Form(s): | INJECTION, SOLUTION |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 52533-034 |
| Labeler Name: | Cantrell Drug Company |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | |
| Marketing Category: | UNAPPROVED DRUG OTHER |
| Start Marketing Date: | 20120223 |
| Package NDC: | 52533-034-16 |
| Package Description: | 2 mL in 1 SYRINGE, PLASTIC (52533-034-16) |
| NDC Code | 52533-034-16 |
| Proprietary Name | Labetalol HCl |
| Package Description | 2 mL in 1 SYRINGE, PLASTIC (52533-034-16) |
| Product NDC | 52533-034 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Labetalol HCl |
| Dosage Form Name | INJECTION, SOLUTION |
| Route Name | INTRAVENOUS |
| Start Marketing Date | 20120223 |
| Marketing Category Name | UNAPPROVED DRUG OTHER |
| Labeler Name | Cantrell Drug Company |
| Substance Name | LABETALOL HYDROCHLORIDE |
| Strength Number | 5 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |